Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$486.62 USD

486.62
740,884

+1.86 (0.38%)

Updated Oct 2, 2024 04:00 PM ET

After-Market: $487.17 +0.55 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Varian Medical (VAR) Misses on Q4 Earnings, Issues FY18 View

Year-over-year decline in Varian Medical's (VAR) proton therapy segment is the primary cause behind the company's lackluster fourth-quarter performance.

    GNC Holdings (GNC) Lags Q3 Earnings & Revenues, Margins Down

    GNC Holdings (GNC) misses the Zacks Consensus Estimate on both the counts in Q3 due to adverse impact from the recent hurricanes and lower sales at the U.S. & Canada and manufacturing/wholesale segments.

      Cardiovascular Systems (CSII) Q1 Earnings Top, Revenues Lag

      Cardiovascular Systems' (CSII) Q1 revenues declined year over year owing to the decline in revenues at both the segments.

        Boston Scientific's (BSX) Q3 Earnings In Line, Guidance Up

        Despite back-to-back natural disasters, Boston Scientific managed to register strong year-over-year increase in both earnings and revenues in the third quarter on balanced growth across all segments.

          McKesson (MCK) Beats Earnings & Revenue Estimates in Q2

          McKesson (MCK) reported strong second-quarter numbers owing to stable performance from Distribution Solutions business.

            The Zacks Analyst Blog Highlights: Lockheed Martin, 3M, T-Mobile, Broadcom and Intuitive Surgical.

            The Zacks Analyst Blog Highlights: Lockheed Martin, 3M, T-Mobile, Broadcom and Intuitive Surgical.

              Thermo Fisher (TMO) Q3 Earnings & Sales Top, Guidance Up

              On solid third-quarter performance, a favorable foreign exchange environment and the recently closed acquisition of Patheon, Thermo Fisher (TMO) has raised its full-year 2017 guidance.

                LabCorp (LH) Beats Q3 Earnings Estimates, Raises Guidance

                Banking on strong third-quarter show and considering a gradually improving foreign exchange scenario, LabCorp (LH) increased its earlier provided 2017 outlook.

                  Walgreens Boots (WBA) Tops Q4 Earnings, Issues 2018 View

                  Walgreens Boots (WBA) surpasses the Zacks Consensus Estimate for both the counts in Q4 on continued prescription growth and strength in the Retail Pharmacy USA division.

                    Baxter (BAX) Beats on Earnings & Sales in Q3, 2017 View Up

                    Baxter (BAX) exited the third quarter on a solid note, courtesy of stellar performances by the company's hospital products and renal segments.

                      NuVasive (NUVA) Q3 Earnings Top, Revenues Lag, Guidance Cut

                      NuVasive's robust top-line growth in Q3 was driven by strong international performance. However, U.S. sales declined on procedural volume challenges and an adverse impact of the recent natural disasters.

                        Accuray's (ARAY) Q1 Loss in Line, Revenues Beat Estimates

                        Accuray (ARAY) rides high on its product and service segments in Q1.

                          Illumina (ILMN) Tops Q3 Earnings & Revenues, Raises Guidance

                          Illumina (ILMN) rides high on sequencing consumables and instruments as well as microarray portfolios in Q3 earnings.

                            Abaxis (ABAX) Posts In-Line Earnings in Q2, Lags Revenues

                            Abaxis (ABAX) misses the Zacks Consensus Estimate for revenues due to softness in the medical market in Q2. Weak margins are a concern as well.

                              Edwards Lifesciences (EW) Q3 Earnings, Sales Lag, View Intact

                              Edwards Lifesciences (EW) misses the Zacks Consensus Estimate on both the counts in Q3 due to adverse impact from recent natural disasters in the Caribbean and the United States.

                                Intuitive Surgical (ISRG) Beats on Q3 Earnings & Revenues

                                Intuitive Surgical (ISRG) posted solid numbers in the third quarter, courtesy of rising customer adoption of procedures and growth in system placements.

                                  Tracey Ryniec headshot

                                  This Week's Amazing Earnings Charts

                                  Don't look now, but these 5 companies have some of the best earnings track records and charts this week.

                                    Will Intuitive Surgical (ISRG) Disappoint in Q3 Earnings?

                                    We believe that the growing adoption of Intuitive Surgical's (ISRG) da Vinci system among physicians for general surgery, oncology, urology and gynecology procedures is a catalyst for the quarter.

                                      Varian Medical Initiates Treatment Using Halcyon System

                                      Varian Medical (VAR) has been taking initiatives to gain customers for its broad spectrum of products.

                                        Mazor Robotics Gets CE Mark for Surgical Assurance Platform

                                        Earlier this year, Mazor Robotics (MZOR) had announced the receipt of FDA clearance for its Mazor X Align software.

                                          Intuitive Surgical (ISRG) Well Poised on Procedural Business

                                          Intuitive Surgical's (ISRG) strong sales growth will continue to be aided by focus on da Vinci system and procedural growth from general surgery, oncology, urology and gynecology.

                                            Intuitive Surgical at 52-Week High: What's Driving the Stock?

                                            Share price of Intuitive Surgical (ISRG) reaches a new 52-week high on the back of its new partnership and impressive second-quarter performance.

                                              The Zacks Analyst Blog Highlights: Facebook, Air Liquide and Intuitive Surgical

                                              The Zacks Analyst Blog Highlights: Facebook, Air Liquide and Intuitive Surgical

                                                John Blank headshot

                                                Watch Out for the Three Stooges: Global Week Ahead

                                                Q2's biggest earnings week, minutes from the latest FOMC meeting and U.S. GDP Friday may be the Three Musketeers charging markets higher... or, they may become the Three Stooges instead.

                                                  Intuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues

                                                  Intuitive Surgical posted solid numbers in the quarter under review, courtesy of rising customer adoption of procedures and growth in system placements.